Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - FENNEC PHARMACEUTICALS INC. | v467306_8k.htm |
Exhibit 16.1
May 17, 2017
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-7561
Dear Sirs/Madams:
We have read Item 4.01 of Fennec Pharmaceuticals Inc.'s Form 8-K dated May 17, 2017, and have the following comments:
| 1. | We agree with the statements made in section (a) of Item 4.01. |
| 2. | We have no basis on which to agree or disagree with the statements made in section (b) of Item 4.01. |
Yours truly,
/s/ Deloitte LLP
Chartered Professional Accountants
Licensed Public Accountants